About Orchestra Biomed Holdings Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: http://www.orchestrabiomed.com
Frequently Asked Questions
What is the 52-week range for OBIO?
The 52-week high is $6.5 and the 52-week low is $2.418.
What is the P/E ratio for OBIO?
The P/E ratio data is currently unavailable.
What is the dividend yield for OBIO?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -125.78%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -184.39%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 3.70.
Analyst Recommendation Trends
Wall Street analyst consensus for OBIO over the last few months:
Latest OBIO News
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
330 patients randomized as of September 30, 2026, surpassing full trial enrollment targetCompany reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major cardiovascular conference in Q2 2027 Data expected to support future marketing application submissions by Medtronic to the FDA and other global regulatory agencies NEW HOPE, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or
Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?
Orchestra BioMed Holdings, Inc. (OBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026
Sessions will highlight Orchestra BioMed's collaboration with Medtronic and explore the potential for AVIM Therapy to treat hypertensive heart disease in pacemaker-indicated patients and beyondNEW HOPE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) ("Orchestra BioMed" or the "Company"), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
Payment follows approximately $5 million received in January 2026, bringing total cash proceeds received to approximately $11 millionCompany remains eligible for up to approximately $10 million in additional proceeds through future revenue earnoutsMonetization of a strategic holding provides additional capital to advance Orchestra BioMed’s pivotal programs and reflects its approach to creating value through partnerships NEW HOPE, Pa., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings,
This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday
Analysts upgraded Copart, Orchestra BioMed, Illumina, Martin Marietta Materials and Waters, raising their price targets.
Crude Oil Surges 6%; Macy’s Shares Fall After Q2 Results
U.S. stocks fell Thursday as the Dow dropped 300+ points; Macy’s slid on weak guidance, while oil rose and producer prices accelerated.
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
This Meta Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Analysts upgraded SFNC, OBIO, and more.
BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target
BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-10 | Hochman David P | -3,283 | $5.81 | $19,074 |
| 2026-09-10 | Hochman David P | -3,283 | $5.81 | $19,074 |
| 2026-09-03 | Hochman David P | +10,000 | $4.79 | $47,900 |
| 2026-09-01 | Sherman Darren | -15,000 | $4.94 | $74,100 |
| 2026-08-26 | Aiello Joshua | -203 | $5.26 | $1,068 |
| 2026-08-26 | Taylor Andrew Lawrence | -3,076 | $5.26 | $16,180 |
| 2026-08-26 | Sherman Darren | +2,000 | $5.33 | $10,660 |
| 2026-08-26 | Sherman Darren | -4,925 | $5.26 | $25,906 |
| 2026-08-12 | Mack John Prosper | -4,885 | $4.42 | $21,592 |
| 2026-08-12 | Cleary Chris | -4,238 | $4.42 | $18,732 |
| 2026-08-12 | Pacitti David | -3,761 | $4.42 | $16,624 |
| 2026-08-12 | Fain Eric S | -5,145 | $4.42 | $22,741 |
| 2026-08-03 | Sherman Darren | -15,000 | $4.09 | $61,350 |
| 2026-07-01 | Sherman Darren | -15,000 | $4.27 | $64,050 |
| 2026-06-24 | Cleary Chris | -3,510 | - | - |
| 2026-06-24 | Mack John Prosper | -3,510 | - | - |
| 2026-06-24 | Pacitti David | -3,784 | - | - |
| 2026-06-24 | Fain Eric S | -4,261 | - | - |
| 2026-06-23 | Cleary Chris | +42,553 | - | - |
| 2026-06-23 | Mack John Prosper | +34,653 | - | - |
| 2026-06-23 | Connealy Pamela Ann | +21,277 | - | - |
| 2026-06-23 | Connealy Pamela Ann | +17,327 | - | - |
| 2026-06-23 | Pacitti David | +21,277 | - | - |
| 2026-06-23 | Pacitti David | +17,327 | - | - |
| 2026-06-23 | Fain Eric S | +21,277 | - | - |
| 2026-06-23 | Fain Eric S | +17,327 | - | - |
| 2026-06-23 | Aryeh Jason | +42,553 | - | - |
| 2026-06-10 | Taylor Andrew Lawrence | -36,352 | $4.02 | $146,135 |
| 2026-06-10 | Hochman David P | -3,283 | $4.02 | $13,198 |
| 2026-06-10 | Hochman David P | -3,283 | $4.02 | $13,198 |
| 2026-06-01 | Sherman Darren | -15,000 | $3.87 | $58,050 |
| 2026-06-01 | Hochman David P | +5,000 | $3.83 | $19,150 |
| 2026-05-28 | Taylor Andrew Lawrence | -3,076 | $3.98 | $12,242 |
| 2026-05-28 | Sherman Darren | -4,925 | $3.98 | $19,602 |
| 2026-05-18 | Aryeh Jason | +665 | $3.75 | $2,494 |
| 2026-05-15 | Aryeh Jason | +8,971 | $3.9 | $34,987 |
| 2026-05-15 | Hochman David P | +5,000 | $3.77 | $18,850 |
| 2026-05-14 | Fain Eric S | +20,000 | $4.13 | $82,600 |
| 2026-04-27 | RTW INVESTMENTS, LP | -1,250,032 | $2.7499 | $3,437,463 |
| 2026-04-27 | RTW INVESTMENTS, LP | -32 | $4.13 | $132 |
| 2026-04-27 | RTW INVESTMENTS, LP | +1,250,032 | $0.0001 | $125 |
| 2026-03-25 | Aiello Joshua | -241 | $4.57 | $1,101 |
| 2026-03-25 | Sherman Darren | -33,317 | $4.57 | $152,259 |
| 2026-03-25 | Hochman David P | -32,438 | $4.57 | $148,242 |
| 2026-03-13 | Hochman David P | +10,000 | $4.29 | $42,900 |
| 2026-02-12 | Aiello Joshua | +70,000 | - | - |
| 2026-02-12 | Taylor Andrew Lawrence | +181,000 | - | - |
| 2026-02-12 | Sherman Darren | +397,000 | - | - |
| 2026-02-12 | Hochman David P | +504,000 | - | - |
| 2026-02-05 | Cleary Chris | -676 | $3.71 | $2,508 |
| 2026-01-28 | Sherman Darren | +34,974 | - | - |
| 2026-01-02 | Aiello Joshua | -241 | $4.31 | $1,039 |
| 2026-01-02 | Taylor Andrew Lawrence | -3,452 | $4.31 | $14,878 |
| 2026-01-02 | Sherman Darren | -5,588 | $4.31 | $24,084 |
| 2025-12-10 | Taylor Andrew Lawrence | -8,670 | $4.67 | $40,489 |
| 2025-12-10 | Hochman David P | -3,283 | $4.67 | $15,332 |
| 2025-12-10 | Hochman David P | -40,355 | $4.67 | $188,458 |
| 2025-11-25 | Taylor Andrew Lawrence | -3,071 | $5.35 | $16,430 |
| 2025-11-25 | Sherman Darren | -40,340 | $5.35 | $215,819 |
| 2025-11-14 | Hochman David P | +5,000 | $4.07 | $20,350 |
| 2025-11-13 | Hochman David P | -3,283 | $4.18 | $13,723 |
| 2025-11-13 | Hochman David P | -3,283 | $4.18 | $13,723 |